Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

165.60SEK
17 Aug 2018
Change (% chg)

0.60kr (+0.36%)
Prev Close
165.00kr
Open
168.40kr
Day's High
168.40kr
Day's Low
164.00kr
Volume
15,000
Avg. Vol
40,457
52-wk High
168.40kr
52-wk Low
82.00kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 46.33 49.00 44.00 --
Quarter Ending Dec-18 3 59.33 63.00 54.00 --
Year Ending Dec-18 3 194.00 200.00 187.00 208.00
Year Ending Dec-19 3 282.33 306.00 237.00 295.50
Earnings (per share)
Quarter Ending Sep-18 3 0.14 0.29 0.04 --
Quarter Ending Dec-18 3 0.31 0.52 0.21 --
Year Ending Dec-18 3 0.73 1.10 0.53 0.90
Year Ending Dec-19 3 1.51 2.37 1.03 1.93
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 337.69 38.05 30.45
P/E High - Last 5 Yrs. 1,335.76 41.69 47.36
P/E Low - Last 5 Yrs. 81.37 24.85 24.74
Beta 0.67 0.77 0.84
Price to Sales (TTM) 26.71 6.88 5.98
Price to Book (MRQ) 8.17 5.91 3.69
Price to Tangible Book (MRQ) 15.88 11.25 5.63
Price to Cash Flow (TTM) 151.98 29.65 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.92 1.78
Dividend Yield - 5 Year Avg 0.00 1.08 1.46
Dividend 5 Year Growth Rate -- 17.13 -5.93
Payout Ratio(TTM) 0.00 32.50 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 24.45 6.51 7.18
Sales (TTM) vs TTM 1 Yr. Ago 12.26 11.49 12.05
Sales - 5 Yr. Growth Rate -- 10.04 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 254.00 18.51 23.85
EPS (TTM) vs TTM 1 Yr. Ago 5,723.74 -- --
EPS - 5 Yr. Growth Rate -- 15.08 7.52
Capital Spending - 5 Yr. Growth Rate -- 7.11 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 6.60 2.26 2.50
Current Ratio (MRQ) 7.36 2.97 3.53
LT Debt to Equity (MRQ) 0.00 22.87 11.27
Total Debt to Equity (MRQ) 0.00 29.47 14.23
Interest Coverage (TTM) 35.65 20.44 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 74.04 58.60 55.23
Gross Margin - 5 Yr. Avg. 74.73 58.24 53.33
EBITD Margin (TTM) 17.72 -- --
EBITD - 5 Yr. Avg 16.05 23.76 15.82
Operating Margin (TTM) 7.56 19.55 3.86
Operating Margin - 5 Yr. Avg. 6.30 16.26 10.95
Pre-Tax Margin (TTM) 9.76 18.96 4.16
Pre-Tax Margin - 5 Yr. Avg. 6.44 16.03 11.12
Net Profit Margin (TTM) 7.95 14.88 0.98
Net Profit Margin - 5 Yr. Avg. 4.67 11.18 7.47
Effective Tax Rate (TTM) 18.49 20.86 20.36
Effective Tax Rate - 5 Yr. Avg. 27.49 27.52 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 5,599,862 19,339,261 718,909,906
Net Income/Employee (TTM) 445,379 2,236,588 83,624,743
Receivable Turnover (TTM) 4.11 5.05 5.38
Inventory Turnover (TTM) 1.36 3.15 3.51
Asset Turnover (TTM) 0.29 0.77 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 2.33 11.07 10.04
Return on Assets - 5 Yr. Avg. 2.17 9.56 10.94
Return on Investment (TTM) 2.48 14.28 12.63
Return on Investment - 5 Yr. Avg. 2.40 12.45 14.14
Return on Equity (TTM) 2.49 17.47 14.82
Return on Equity - 5 Yr. Avg. 2.44 15.12 15.50
  1 Year 3 Year 5 Year
Sales % 7.36 20.54 --
EPS (TTM) % 269.82 0.46 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xvivo Perfusion AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 33.33 -- 99 9
13 Week 58.32 -- 99 37
26 Week 83.39 -- 99 82
52 Week 79.03 -- 99 88
YTD 76.17 -- 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 44.99%
# of Holders: 17
Total Shares Held: 11,783,880
3 Mo. Net Change: 265,783
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 0
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.